Synthesis of [18F]-Labeled (6-Fluorohexyl)triphenylphosphonium Cation as a Potential Agent for Myocardial imaging using Positron Emission Tomography

Synthesis of [18F]-Labeled (6-Fluorohexyl)triphenylphosphonium Cation as a Potential Agent for Myocardial imaging using Positron Emission Tomography
复制标题

DOI:
10.1021/bc2004439
复制
发表时间:
2012-03-01
影响因子:
4.7
通讯作者:
Min, Jung-Joon
Min, Jung-Joon
中科院分区:
化学2区
文献类型:
--
作者:
Kim, Dong-Yeon;Kim, Hee-Jung;Min, Jung-Joon

文献摘要

被引文献

相似文献

亲脂性阳离子如鳞盐穿透质膜和线粒体膜的疏水屏障,并响应于负的跨膜内电位而在线粒体中积累。因此,作为新开发的非侵入性显像剂,[F-18]标记的鏻盐可作为分子“电压传感器”探针,以研究线粒体的作用,特别是在心肌疾病中。本研究报告了放射合成的(6-氟己基)三苯基鏻盐(3)作为一种潜在的药物,心肌显像,通过使用正电子发射断层扫描(PET)。通过三步亲核取代反应合成了参考化合物(6-[F-18]氟己基)三苯基鏻盐([F-18]3),产率为74%。在Kryptofix 2.2.2和K2 CO 3存在下,通过无载体添加的[F-18]氟化物与前体己烷-1,6-二基双(4-甲基苯磺酸盐)的两步亲核取代反应对参比化合物进行放射性标记。以15-20%的产率合成放射性标记的化合物。经HPLC分析,放射化学纯度>98%,比活度>6.10-6.47 TBq/μ mol。细胞摄取试验显示心肌细胞优先摄取[F-18]3。[F-18]3在小鼠和大鼠体内的生物分布和micro-PET成像研究结果显示,[F-18]3优先在心肌中蓄积。结果表明,这种化合物将是一个有前途的候选心肌显像。
Lipophilic cations such as phosphonium salts penetrate the hydrophobic barriers of the plasma and mitochondrial membranes and accumulate in mitochondria in response to the negative inner-transmembrane potentials. Thus, as newly developed noninvasive imaging agents, [F-18]-labeled phosphonium salts may serve as molecular "voltage sensor" probes to investigate the role of mitochondria, particularly in myocardial disease. The present study reports the radiosynthesis of (6-fluorohexyl)triphenylphosphonium salt (3) as a potential agent for myocardial imaging by using positron emission tomography (PET). The reference compound of (6-[F-18]fluorohexyl)triphenylphosphonium salt ([F-18]3) was synthesized with 74% yield via three-step nucleophilic substitution reactions. The reference compound was radiolabeled via two-step nucleophilic substitution reactions of no-carrier-added [F-18]fluoride with the precursor hexane-1,6-diyl bis(4-methylbenzenesulfonate) in the presence of Kryptofix 2.2.2 and K2CO3. The radiolabeled compound was synthesized with 15-20% yield. The radiochemical purity was >98% by analytical HPLC, and the specific activity was >6.10-6.47 TBq/mu mol. The cellular uptake assay showed preferential uptake of [F-18]3 in cardiomyocytes. The results of biodistribution and micro-PET imaging studies of [F-18]3 in mice and rats showed preferential accumulation in the myocardium. The results suggest that this compound would be a promising candidate for myocardial imaging.